From the emergence to the end of Anvisa’s prior consent: a critical analysis of pharmaceutical patenting in Brazil. Rev. Digit. Direito Adm. [Internet]. 2024 Feb. 26 [cited 2024 May 18];11(1):307-34. Available from: https://periodicos.usp.br/rdda/article/view/218179